Coupang Inc vs TG Therapeutics Inc — how do they compare? Coupang Inc trades at $16.32 (market cap $29.34B), while TG Therapeutics Inc trades at $47.68 (market cap $7.58B). The key difference: Coupang Inc is far larger — about 3.9× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals.
| CPNG | TGTX | |
|---|---|---|
Market Cap | $29.34B | $7.58B |
Sector | Consumer Cyclical | Health |
52-Week High | $33.53 | $59.06 |
52-Week Low | $15.12 | $26.94 |
Enterprise Value | $28.86B | $7.78B |
Trailing returns across standard periods
Latest headlines on both assets
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →